Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar;63(3):417-429.
doi: 10.1002/mc.23661. Epub 2023 Nov 20.

YTHDF1 enhances stemness and chemoresistance in triple-negative breast cancer cells by upregulating SIAH2

Anhao Wu  1 , Xi Wang  1 , Fang Zhang  2 , Xin Yang  3 , Yuhang Quan  4 , Junyu Dong  1 , Yafang Lai  5 , Dechun Yang  1 , Jian Sun  1 , Maohua Wang  1
Affiliations

YTHDF1 enhances stemness and chemoresistance in triple-negative breast cancer cells by upregulating SIAH2

Anhao Wu et al. Mol Carcinog. 2024 Mar.

Abstract

Triple-negative breast cancer (TNBC) is the most lethal and aggressive subtype of breast cancer, and chemoresistance is the major determinant of TNBC treatment failure. This study explores the molecular mechanism of TNBC chemoresistance. The Cancer Genome Atlas, breast cancer integrative platform, and GEPIA databases were used to analyze the expression and correlation of YTHDF1 and seven in absentia homology 2 (SIAH2) in breast cancer. Knockdown of YTHDF1 and SIAH2, or overexpression of SIAH2 in vitro and in vivo, was conducted to evaluate the impact of changes in YTHDF1 and SIAH2 expression on TNBC cell proliferation, apoptosis, stemness, drug resistance, and Hippo pathway gene expression. YTHDF1 and SIAH2 were highly expressed in breast cancer patients and TNBC cells. Knockdown of YTHDF1 and SIAH2 significantly inhibited proliferation and stemness and promoted apoptosis and chemosensitivity of TNBC cells. Mechanistically, the knockdown of YTHDF1 inhibited the expression of SIAH2, thereby downregulating the Hippo pathway, which inhibited proliferation and stemness and promoted apoptosis and chemosensitivity of TNBC cells. The current findings revealed the regulatory mechanism of YTHDF1 in TNBC and clarified the role of the YTHDF1/SIAH2 axis in TNBC drug resistance and stemness. This could provide new insights into the vital role of targeting YTHDF1/SIAH2 to suppress drug resistance and stemness in TNBC cells.

Keywords: Hippo pathway; SIAH2; YTHDF1; drug resistance; stemness; triple-negative breast cancer.

PubMed Disclaimer

References

REFERENCES

    1. Zhu Y, Liu Z, Gui L, et al. Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancer. NPJ Breast Cancer. 2023;9(1):34.
    1. Liu R, Shi D, Guo L, et al. Ultrasound-targeted microbubble disruption with key nanodroplets for effective ferroptosis in triple-negative breast cancer using animal model. Int J Nanomedicine. 2023;18:2037-2052.
    1. Bobrie A, Massol O, Ramos J, et al. Association of CD206 protein expression with immune infiltration and prognosis in patients with triple-negative breast cancer. Cancers. 2022;14(19):4829.
    1. Mayer EL, Abramson V, Jankowitz R, et al. TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Ann Oncol. 2020;31(11):1518-1525.
    1. Pantelaiou-Prokaki G, Mieczkowska I, Schmidt GE, et al. HDAC8 suppresses the epithelial phenotype and promotes EMT in chemotherapy-treated basal-like breast cancer. Clin Epigenetics. 2022;14(1):7.

MeSH terms

LinkOut - more resources